ISDA

Entry Detail

PDB ID:

6X5L

Keywords:

BLOOD CLOTTING

Title:

Discovery of Hydroxy Pyrimidine Factor IXa Inhibitors

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2020-05-26

Release Date:

2020-06-24

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.25 Å

R-Value Free:

0.23

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 43 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Coagulation factor IX
Chain IDs:A
Chain Length:234
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P00740 Pfam ID:PF00089, PF14670 EC:3.4.21.22

Protein Blast

Polymer Type:polypeptide(L)
Description:Coagulation factor IX
Chain IDs:B
Chain Length:62
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P00740 Pfam ID:PF00089, PF14670 EC:3.4.21.22

Ligand Molecules

CIT

GOL

UQG

Primary Citation

Discovery of hydroxy pyrimidine Factor IXa inhibitors.

Jayne, C.L, Andreani, T, Chan, T.Y, Chelliah, M.V, Clasby, M.C, Dwyer, M, Eagen, K.A, Fried, S, Greenlee, W.J, Guo, Z, Hawes, B, Hruza, A, Ingram, R, Keertikar, K.M, Neelamkavil, S, Reichert, P, Xia, Y, Chackalamannil, S.Show

Bioorg.Med.Chem.Lett. 30 127279 127279 (2020)

PMID: 32527459 DOI: 10.1016/j.bmcl.2020.127279

Abstact

The synthesis and structure activity relationship development of a pyrimidine series of heterocyclic Factor IXa inhibitors is described. Increased selectivity over Factor Xa inhibition was achieved through SAR expansion of the P1 element. Select compounds were evaluated in vivo to assess their plasma levels in rat.

Legend

Protein

Chemical

Disease

Primary Citation of related structures